0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-fishy Smell Syndrome Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-34X13606
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anti fishy Smell Syndrome Drugs Market Research Report 2023
BUY CHAPTERS

Global Anti-fishy Smell Syndrome Drugs Market Research Report 2025

Code: QYRE-Auto-34X13606
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-fishy Smell Syndrome Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-fishy Smell Syndrome Drugs Market

Anti-fishy Smell Syndrome Drugs Market

The global market for Anti-fishy Smell Syndrome Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-fishy Smell Syndrome Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-fishy Smell Syndrome Drugs.
The Anti-fishy Smell Syndrome Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-fishy Smell Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-fishy Smell Syndrome Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-fishy Smell Syndrome Drugs Market Report

Report Metric Details
Report Name Anti-fishy Smell Syndrome Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Novartis AG, Johnson and Johnson, Sanofi SA, Merck Co & Inc., F. Hoffmann-La Roche AG, AbbVie Inc., GlaxoSmithKline plc., EliLilly and Company, Takeda Pharmaceuticals, Teva Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-fishy Smell Syndrome Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-fishy Smell Syndrome Drugs Market report?

Ans: The main players in the Anti-fishy Smell Syndrome Drugs Market are Pfizer Inc., Novartis AG, Johnson and Johnson, Sanofi SA, Merck Co & Inc., F. Hoffmann-La Roche AG, AbbVie Inc., GlaxoSmithKline plc., EliLilly and Company, Takeda Pharmaceuticals, Teva Pharmaceuticals

What are the Application segmentation covered in the Anti-fishy Smell Syndrome Drugs Market report?

Ans: The Applications covered in the Anti-fishy Smell Syndrome Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Anti-fishy Smell Syndrome Drugs Market report?

Ans: The Types covered in the Anti-fishy Smell Syndrome Drugs Market report are Antibiotics, Vitamin B12 Supplements, Others

Recommended Reports

Pharmaceutical Drugs

Diagnostics & Therapeutics

Medical Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-fishy Smell Syndrome Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibiotics
1.2.3 Vitamin B12 Supplements
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anti-fishy Smell Syndrome Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-fishy Smell Syndrome Drugs Market Perspective (2020-2031)
2.2 Global Anti-fishy Smell Syndrome Drugs Growth Trends by Region
2.2.1 Global Anti-fishy Smell Syndrome Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-fishy Smell Syndrome Drugs Historic Market Size by Region (2020-2025)
2.2.3 Anti-fishy Smell Syndrome Drugs Forecasted Market Size by Region (2026-2031)
2.3 Anti-fishy Smell Syndrome Drugs Market Dynamics
2.3.1 Anti-fishy Smell Syndrome Drugs Industry Trends
2.3.2 Anti-fishy Smell Syndrome Drugs Market Drivers
2.3.3 Anti-fishy Smell Syndrome Drugs Market Challenges
2.3.4 Anti-fishy Smell Syndrome Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-fishy Smell Syndrome Drugs Players by Revenue
3.1.1 Global Top Anti-fishy Smell Syndrome Drugs Players by Revenue (2020-2025)
3.1.2 Global Anti-fishy Smell Syndrome Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Anti-fishy Smell Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-fishy Smell Syndrome Drugs Revenue
3.4 Global Anti-fishy Smell Syndrome Drugs Market Concentration Ratio
3.4.1 Global Anti-fishy Smell Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-fishy Smell Syndrome Drugs Revenue in 2024
3.5 Global Key Players of Anti-fishy Smell Syndrome Drugs Head office and Area Served
3.6 Global Key Players of Anti-fishy Smell Syndrome Drugs, Product and Application
3.7 Global Key Players of Anti-fishy Smell Syndrome Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-fishy Smell Syndrome Drugs Breakdown Data by Type
4.1 Global Anti-fishy Smell Syndrome Drugs Historic Market Size by Type (2020-2025)
4.2 Global Anti-fishy Smell Syndrome Drugs Forecasted Market Size by Type (2026-2031)
5 Anti-fishy Smell Syndrome Drugs Breakdown Data by Application
5.1 Global Anti-fishy Smell Syndrome Drugs Historic Market Size by Application (2020-2025)
5.2 Global Anti-fishy Smell Syndrome Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-fishy Smell Syndrome Drugs Market Size (2020-2031)
6.2 North America Anti-fishy Smell Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025)
6.4 North America Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-fishy Smell Syndrome Drugs Market Size (2020-2031)
7.2 Europe Anti-fishy Smell Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025)
7.4 Europe Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Size (2020-2031)
8.2 Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-fishy Smell Syndrome Drugs Market Size (2020-2031)
9.2 Latin America Anti-fishy Smell Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025)
9.4 Latin America Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Size (2020-2031)
10.2 Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Anti-fishy Smell Syndrome Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Anti-fishy Smell Syndrome Drugs Introduction
11.2.4 Novartis AG Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Details
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Anti-fishy Smell Syndrome Drugs Introduction
11.3.4 Johnson and Johnson Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.3.5 Johnson and Johnson Recent Development
11.4 Sanofi SA
11.4.1 Sanofi SA Company Details
11.4.2 Sanofi SA Business Overview
11.4.3 Sanofi SA Anti-fishy Smell Syndrome Drugs Introduction
11.4.4 Sanofi SA Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.4.5 Sanofi SA Recent Development
11.5 Merck Co & Inc.
11.5.1 Merck Co & Inc. Company Details
11.5.2 Merck Co & Inc. Business Overview
11.5.3 Merck Co & Inc. Anti-fishy Smell Syndrome Drugs Introduction
11.5.4 Merck Co & Inc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.5.5 Merck Co & Inc. Recent Development
11.6 F. Hoffmann-La Roche AG
11.6.1 F. Hoffmann-La Roche AG Company Details
11.6.2 F. Hoffmann-La Roche AG Business Overview
11.6.3 F. Hoffmann-La Roche AG Anti-fishy Smell Syndrome Drugs Introduction
11.6.4 F. Hoffmann-La Roche AG Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.6.5 F. Hoffmann-La Roche AG Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Anti-fishy Smell Syndrome Drugs Introduction
11.7.4 AbbVie Inc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.7.5 AbbVie Inc. Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Details
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Anti-fishy Smell Syndrome Drugs Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 EliLilly and Company
11.9.1 EliLilly and Company Company Details
11.9.2 EliLilly and Company Business Overview
11.9.3 EliLilly and Company Anti-fishy Smell Syndrome Drugs Introduction
11.9.4 EliLilly and Company Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.9.5 EliLilly and Company Recent Development
11.10 Takeda Pharmaceuticals
11.10.1 Takeda Pharmaceuticals Company Details
11.10.2 Takeda Pharmaceuticals Business Overview
11.10.3 Takeda Pharmaceuticals Anti-fishy Smell Syndrome Drugs Introduction
11.10.4 Takeda Pharmaceuticals Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.10.5 Takeda Pharmaceuticals Recent Development
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Details
11.11.2 Teva Pharmaceuticals Business Overview
11.11.3 Teva Pharmaceuticals Anti-fishy Smell Syndrome Drugs Introduction
11.11.4 Teva Pharmaceuticals Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
11.11.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Anti-fishy Smell Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antibiotics
 Table 3. Key Players of Vitamin B12 Supplements
 Table 4. Key Players of Others
 Table 5. Global Anti-fishy Smell Syndrome Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Anti-fishy Smell Syndrome Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Anti-fishy Smell Syndrome Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Anti-fishy Smell Syndrome Drugs Market Share by Region (2020-2025)
 Table 9. Global Anti-fishy Smell Syndrome Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Anti-fishy Smell Syndrome Drugs Market Share by Region (2026-2031)
 Table 11. Anti-fishy Smell Syndrome Drugs Market Trends
 Table 12. Anti-fishy Smell Syndrome Drugs Market Drivers
 Table 13. Anti-fishy Smell Syndrome Drugs Market Challenges
 Table 14. Anti-fishy Smell Syndrome Drugs Market Restraints
 Table 15. Global Anti-fishy Smell Syndrome Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Anti-fishy Smell Syndrome Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Anti-fishy Smell Syndrome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fishy Smell Syndrome Drugs as of 2024)
 Table 18. Ranking of Global Top Anti-fishy Smell Syndrome Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Anti-fishy Smell Syndrome Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Anti-fishy Smell Syndrome Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Anti-fishy Smell Syndrome Drugs, Product and Application
 Table 22. Global Key Players of Anti-fishy Smell Syndrome Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Anti-fishy Smell Syndrome Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Anti-fishy Smell Syndrome Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Anti-fishy Smell Syndrome Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Anti-fishy Smell Syndrome Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Anti-fishy Smell Syndrome Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Anti-fishy Smell Syndrome Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Anti-fishy Smell Syndrome Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Anti-fishy Smell Syndrome Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Anti-fishy Smell Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Anti-fishy Smell Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Anti-fishy Smell Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pfizer Inc. Company Details
 Table 48. Pfizer Inc. Business Overview
 Table 49. Pfizer Inc. Anti-fishy Smell Syndrome Drugs Product
 Table 50. Pfizer Inc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 51. Pfizer Inc. Recent Development
 Table 52. Novartis AG Company Details
 Table 53. Novartis AG Business Overview
 Table 54. Novartis AG Anti-fishy Smell Syndrome Drugs Product
 Table 55. Novartis AG Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 56. Novartis AG Recent Development
 Table 57. Johnson and Johnson Company Details
 Table 58. Johnson and Johnson Business Overview
 Table 59. Johnson and Johnson Anti-fishy Smell Syndrome Drugs Product
 Table 60. Johnson and Johnson Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 61. Johnson and Johnson Recent Development
 Table 62. Sanofi SA Company Details
 Table 63. Sanofi SA Business Overview
 Table 64. Sanofi SA Anti-fishy Smell Syndrome Drugs Product
 Table 65. Sanofi SA Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 66. Sanofi SA Recent Development
 Table 67. Merck Co & Inc. Company Details
 Table 68. Merck Co & Inc. Business Overview
 Table 69. Merck Co & Inc. Anti-fishy Smell Syndrome Drugs Product
 Table 70. Merck Co & Inc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 71. Merck Co & Inc. Recent Development
 Table 72. F. Hoffmann-La Roche AG Company Details
 Table 73. F. Hoffmann-La Roche AG Business Overview
 Table 74. F. Hoffmann-La Roche AG Anti-fishy Smell Syndrome Drugs Product
 Table 75. F. Hoffmann-La Roche AG Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 76. F. Hoffmann-La Roche AG Recent Development
 Table 77. AbbVie Inc. Company Details
 Table 78. AbbVie Inc. Business Overview
 Table 79. AbbVie Inc. Anti-fishy Smell Syndrome Drugs Product
 Table 80. AbbVie Inc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 81. AbbVie Inc. Recent Development
 Table 82. GlaxoSmithKline plc. Company Details
 Table 83. GlaxoSmithKline plc. Business Overview
 Table 84. GlaxoSmithKline plc. Anti-fishy Smell Syndrome Drugs Product
 Table 85. GlaxoSmithKline plc. Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 86. GlaxoSmithKline plc. Recent Development
 Table 87. EliLilly and Company Company Details
 Table 88. EliLilly and Company Business Overview
 Table 89. EliLilly and Company Anti-fishy Smell Syndrome Drugs Product
 Table 90. EliLilly and Company Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 91. EliLilly and Company Recent Development
 Table 92. Takeda Pharmaceuticals Company Details
 Table 93. Takeda Pharmaceuticals Business Overview
 Table 94. Takeda Pharmaceuticals Anti-fishy Smell Syndrome Drugs Product
 Table 95. Takeda Pharmaceuticals Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 96. Takeda Pharmaceuticals Recent Development
 Table 97. Teva Pharmaceuticals Company Details
 Table 98. Teva Pharmaceuticals Business Overview
 Table 99. Teva Pharmaceuticals Anti-fishy Smell Syndrome Drugs Product
 Table 100. Teva Pharmaceuticals Revenue in Anti-fishy Smell Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 101. Teva Pharmaceuticals Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. Anti-fishy Smell Syndrome Drugs Picture
 Figure 2. Global Anti-fishy Smell Syndrome Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-fishy Smell Syndrome Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Antibiotics Features
 Figure 5. Vitamin B12 Supplements Features
 Figure 6. Others Features
 Figure 7. Global Anti-fishy Smell Syndrome Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Anti-fishy Smell Syndrome Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Others Case Studies
 Figure 12. Anti-fishy Smell Syndrome Drugs Report Years Considered
 Figure 13. Global Anti-fishy Smell Syndrome Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Anti-fishy Smell Syndrome Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Anti-fishy Smell Syndrome Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Anti-fishy Smell Syndrome Drugs Market Share by Players in 2024
 Figure 17. Global Top Anti-fishy Smell Syndrome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fishy Smell Syndrome Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Anti-fishy Smell Syndrome Drugs Revenue in 2024
 Figure 19. North America Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Anti-fishy Smell Syndrome Drugs Market Share by Country (2020-2031)
 Figure 21. United States Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Anti-fishy Smell Syndrome Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Anti-fishy Smell Syndrome Drugs Market Share by Region (2020-2031)
 Figure 33. China Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Anti-fishy Smell Syndrome Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Anti-fishy Smell Syndrome Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Anti-fishy Smell Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Inc. Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 49. Novartis AG Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 50. Johnson and Johnson Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 51. Sanofi SA Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 52. Merck Co & Inc. Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 53. F. Hoffmann-La Roche AG Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 54. AbbVie Inc. Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 55. GlaxoSmithKline plc. Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 56. EliLilly and Company Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 57. Takeda Pharmaceuticals Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 58. Teva Pharmaceuticals Revenue Growth Rate in Anti-fishy Smell Syndrome Drugs Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Medication for Facial Features Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4D16704
Thu Sep 25 00:00:00 UTC 2025

Add to Cart